Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Giugliani

Showing results (131-140 of 482) with videos related to

Pageof 49
Sort By:
Behavioural Brain Research|May 15, 2012
Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I miceGuilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli, et al.
Orthopedic Reviews|August 3, 2011
Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome SurveyBianca Link, Louise Lapagesse de Camargo Pinto, Roberto Giugliani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 15, 2011
Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome SurveyJoseph Muenzer, Michael Beck, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|November 27, 2012
Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VIAna C M Azevedo, Osvaldo Artigalás, Leonardo Vedolin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 8, 2005
G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosisRenata Sano, Vera M T Trindade, Alessandra Tessitore, et al.
Journal of Tropical Pediatrics|January 12, 2010
Polymorphic variants of UGT1A1 in neonatal jaundice in southern BrazilClarissa Gutiérrez Carvalho, Simone Martins Castro, Ana Paula Santin, et al.
Pediatric Research|May 15, 2012
UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?Laura Alencastro de Azevedo, Themis Reverbel da Silveira, Clarissa Gutierrez Carvalho, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Application of a protocol for the detection of disorders of sialic acid metabolism to 124 high-risk Brazilian patientsCristina D Castilhos, Alexandre S Mello, Maira G Burin, et al.
Journal of Materials Science. Materials in Medicine|February 3, 2017
Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatmentValeska Lizzi Lagranha, Barbara Zambiasi Martinelli, Guilherme Baldo, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 21, 2017
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activityGuilherme Baldo, Angela Maria Vicente Tavares, Esteban Gonzalez, et al.
Pageof 49

Showing results (131-140 of 482) with videos related to

Sort By:
Pageof 49
Behavioural Brain Research|May 15, 2012
Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I miceGuilherme Baldo, Fabiana Quoos Mayer, Barbara Martinelli, et al.
Orthopedic Reviews|August 3, 2011
Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome SurveyBianca Link, Louise Lapagesse de Camargo Pinto, Roberto Giugliani, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 15, 2011
Idursulfase treatment of Hunter syndrome in children younger than 6 years: results from the Hunter Outcome SurveyJoseph Muenzer, Michael Beck, Roberto Giugliani, et al.
Journal of Inherited Metabolic Disease|November 27, 2012
Brain magnetic resonance imaging findings in patients with mucopolysaccharidosis VIAna C M Azevedo, Osvaldo Artigalás, Leonardo Vedolin, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 8, 2005
G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosisRenata Sano, Vera M T Trindade, Alessandra Tessitore, et al.
Journal of Tropical Pediatrics|January 12, 2010
Polymorphic variants of UGT1A1 in neonatal jaundice in southern BrazilClarissa Gutiérrez Carvalho, Simone Martins Castro, Ana Paula Santin, et al.
Pediatric Research|May 15, 2012
UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms vs. neonatal hyperbilirubinemia: is there an association?Laura Alencastro de Azevedo, Themis Reverbel da Silveira, Clarissa Gutierrez Carvalho, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Application of a protocol for the detection of disorders of sialic acid metabolism to 124 high-risk Brazilian patientsCristina D Castilhos, Alexandre S Mello, Maira G Burin, et al.
Journal of Materials Science. Materials in Medicine|February 3, 2017
Subcutaneous implantation of microencapsulated cells overexpressing α-L-iduronidase for mucopolysaccharidosis type I treatmentValeska Lizzi Lagranha, Barbara Zambiasi Martinelli, Guilherme Baldo, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 21, 2017
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activityGuilherme Baldo, Angela Maria Vicente Tavares, Esteban Gonzalez, et al.
Pageof 49